Cite
HARVARD Citation
Pietrantonio, F. et al. (n.d.). O-016First-line FOLFOX plus panitumumab followed by 5-FU/LV plus panitumumab or single-agent panitumumab as maintenance therapy in patients with RAS wild-type metastatic colorectal cancer (mCRC): The VALENTINO study. Annals of oncology. p. . [Online].